Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Certain Optic Cells Export Their Damaged Mitochondria for Destruction Elsewhere

By BiotechDaily International staff writers
Posted on 25 Jun 2014
Print article
Image: Pictured is mouse optic nerve and retina, responsible for relaying information from the eye to the brain. The tissue has been fluorescently stained to reveal the distribution of astrocytes (yellow), retinal ganglion cell axons (purple), myelin (green) and nuclei (cyan). Retinal ganglion cell axons transfer mitochondria to adjacent astrocytes in the optic nerve head behind the retina. Astrocytes degrade the mitochondria in a process called transmitophagy (Photo courtesy of the University of California, San Diego).
Image: Pictured is mouse optic nerve and retina, responsible for relaying information from the eye to the brain. The tissue has been fluorescently stained to reveal the distribution of astrocytes (yellow), retinal ganglion cell axons (purple), myelin (green) and nuclei (cyan). Retinal ganglion cell axons transfer mitochondria to adjacent astrocytes in the optic nerve head behind the retina. Astrocytes degrade the mitochondria in a process called transmitophagy (Photo courtesy of the University of California, San Diego).
A recent paper revealed that certain cells in the eye transfer damaged mitochondria to neighboring cells for destruction (mitophagy) and recycling.

Mitophagy is considered a subset of the process known as autophagy, by which damaged organelles are enwrapped and delivered to lysosomes for degradation. As such, it was always assumed that a cell degraded its own mitochondria. However, results presented in the June 16, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) by investigators at the University of California, San Diego (USA) and Johns Hopkins University (Baltimore, MD, USA) suggest that this assumption may be incorrect.

The investigators used advanced electron microscopy and molecular staining techniques to show that in the optic nerve head, large numbers of mitochondria were shed from neurons to be degraded by the lysosomes of adjoining glial cells. This investigation had been prompted by findings from a glaucoma mouse model that protein products from the retina were accumulating in the optic nerve head just behind the eye.

In the study, a virally introduced tandem fluorophore protein reporter of acidified mitochondria was introduced into mice retinal ganglion cells. The reporter revealed that acidified axonal mitochondria originating from the retinal ganglion cells became associated with lysosomes within columns of astrocytes in the optic nerve head. According to this reporter, a greater proportion of retinal ganglion cell mitochondria were degraded at the optic nerve head than in the ganglions. The investigators coined the term "transmitophagy" to describe this phenomenon.

“It does call into question the conventional assumption that cells necessarily degrade their own organelles. We do not yet know how generalized this process is throughout the brain, but our work suggests it is probably widespread,” said co-senior author Dr. Mark H. Ellisman, professor of neurosciences at the University of California, San Diego. “Mitochondria play prominent roles in the health of axons, which are fundamental to connecting neurons and transmitting information. It should be a priority to further explore what happens in transmitophagy and whether defects in this phenomenon contribute to neuronal dysfunction or disease.”

“The discovery of a standard process for transfer of trash from neuron to glia will most likely be very important to understanding age-related declines in function of the brain and neurodegenerative or metabolic disorders,” said co-senior author Dr. Nicholas Marsh-Armstrong, assistant professor of ophthalmology and neuroscience at Johns Hopkins University. “We expect the impact to be significant in other areas of biomedicine as well.”

Related Links:

University of California, San Diego
Johns Hopkins University



Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.